Journal for Managed Care & Specialty Pharmacy Issues Research Articles in December 2023 Edition

ALEXANDRIA, Virginia, Dec. 8 -- The Journal for Managed Care and Specialty Pharmacy, a peer-reviewed journal that says it strives to engage and serve professionals in pharmacy, medicine, nursing and related fields to optimize the value of pharmaceutical products and pharmacy services delivered to patients from the Academy of Managed Care Pharmacy, published research articles on the following topics in its December 2023 edition (Vol. 29, Issue 12):

Research Brief:

* HIV preexposure prophylaxis treatment patterns in a national health plan population

* Pharmacist impact on evidence-based prescribing of diabetes medications in patients with clinical atherosclerotic cardiovascular disease

Viewpoint:

* Building health plan-pharmacist provider partnerships to optimize medication outcomes

Research:

* Budget impact of oral nirmatrelvir/ritonavir in adults at high risk for progression to severe COVID-19 in the United States

* Descriptive study of the real-world, long-term cost estimates and duration of use for hormonal and nonhormonal intrauterine devices using US commercial insurance claims

* Estimated impact of ECHELON-1 overall survival on productivity costs in stage III/IV classical Hodgkin lymphoma in the United States

* Generalizability of clinical trial efficacy results to a real-world population: An example in migraine prevention

Systematic Review:

* Medication and bone health in multiple sclerosis: A systematic review and meta-analysis

* Economic burden of multiple sclerosis in the United States: A systematic literature review

Managed Care Pharmacy Primer Series:

* A primer on managed care pharmacy

The December 2023 edition of the Journal for Managed Care & Specialty Pharmacy can be viewed at https://www.jmcp.org/toc/jmcsp/29/12.